A Review of Mortality From Choroidal Melanoma: II. A Meta-Analysis of 5-Year Mortality Rates Following Enucleation, 1966 Through 1988

Archives of Ophthalmology

Volumn 110, Issue 2, 1992, Pages 245-250

  Diener West, Marie ^a,b   Hawkins, Barbara S ^a,b   Markowitz, Jan A ^a,b   Schachat, Andrew P ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOROID MELANOMA; COMPUTER ANALYSIS; ENUCLEATION; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR VOLUME;

CHOROID NEOPLASMS; EPIDEMIOLOGIC METHODS; EYE ENUCLEATION; HUMAN; MEDLINE; META-ANALYSIS; RESEARCH DESIGN; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0026595855     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1992.01080140101036     Document Type: Article

References (58)

1. 1. Markowitz JA, Hawkins BS, Diener-West M, Schachat AP. A review of mortality from choroidal melanoma, I: quality of published reports, 1966 through 1988. Arch Ophthalmol. 1992;110:239-244.
2. 2. Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep. 1987;71:7-14.
3. 3. Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep. 1987;71:15-29.
4. 4. Hill D, White V, Jolley D, Mapperson K. Self examination of the breast: is it beneficial? metaanalysis of studies investigating breast self examination and extent of disease in patients with breast cancer. BMJ. 1988;297:271-275.
5. 5. Himel HN, Liberati A, Gelber RD, Chalmers TC. Adjuvant chemotherapy for breast cancer: a pooled estimate based on published randomized control trials. JAMA. 1986;256:1148-1159.
6. 6. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA. 1988;260:652-656.
7. 7. Negri E, La Vecchia C, Bruzzi P, et al. Risk factors for breast cancer: pooled results from three Italian case-control studies. Am J Epidemiol. 1988;128:1207-1215.
8. 8. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomized trials among 28,896 women. N Engl J Med. 1988;319:1681-1692.
9. 9. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC. Adjuvant therapy of colorectal cancer: why we still don't know. JAMA. 1988;259:3571-3578.
10. 10. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA. 1988;260:1910-1916.
11. 11. Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, Hennekens CH. Effect of intravenous streptokinase on acute myocardial infarction: pooled results of randomized trials. N Engl J Med. 1982;307:1180-1182.
12. 12. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
13. 13. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease, I: treatments following myocardial infarction. JAMA. 1988;260:2088-2093.
14. 14. Canner PL. Aspirin in coronary heart disease: comparison of six clinical trials. Isr J Med Sci. 1983;19:413-423.
15. 15. Pieper C, La Croix AZ, Karasek RA. The relation of psychosocial dimensions of work with coronary heart disease risk factors: a meta-analysis of five United States data bases. Am J Epidemiol. 1989;129:483-494.
16. 16. Tyroler HA. Review of lipid-lowering clinical trials in relation to observational epidemiologic studies. Circulation. 1987;76:515-522.
17. 17. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease, II: unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA. 1988;260:2259-2263.
18. 18. Henderson WG, Goldman S, Copeland JG, Moritz TE, Harker LA. Antiplatelet or anticoagulant therapy after coronary artery bypass surgery: a meta-analysis of clinical trials. Ann Intern Med. 1989;111:743-750.
19. 19. Padgett D, Mumford E, Hynes M, Carter R. Meta-analysis of the effects of educational and psychosocial interventions on management of diabetes mellitus. J Clin Epidemiol. 1988;41:1007-1030.
20. 20. Hebert PR, Fiebach NH, Eberlein KA, Taylor JO, Hennekens CH. The community-based randomized trials of pharmacologic treatment of mildto-moderate hypertension. Am J Epidemiol. 1988;127:581-590.
21. 21. Lam W, Sze PC, Sacks HS, Chalmers TC. Meta-analysis of randomised controlled trials of nicotine chewing-gum. Lancet. 1987;2:27-30.
22. 22. Chalmers TC, Berrier J, Hewitt P, et al. Meta-analysis of randomized controlled trials as a method of estimating rare complications of nonsteroidal anti-inflammatory drug therapy. Aliment Pharmacol Ther. 1988;2(suppl):9-26.
23. 23. Dyer AR. A method for combining results from several prospective epidemiologic studies. Stat Med. 1986;5:303-317.
24. 24. Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet. 1987;1:902-906.
25. 25. Morgenstern H, Glazer WM, Niedzwiecki D, Nourjah P. The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies. Am JPublic Health. 1987;77:717-724.
26. 26. Needleman HL, Gatsonis CA. Low-level lead exposure and the IQ of children: a meta-analysis of modern studies. JAMA. 1990;263:673-678.
27. 27. Furberg CD, Morgan TM. Lessons from overviews of cardiovascular trials. Stat Med. 1987;6:295-303.
28. 28. Gelber RD, Goldhirsch A. The concept of an overview of cancer clinical trials with special emphasis on early breast cancer. J Clin Oncol. 1986;4:1696-1703.
29. 29. Gerbarg ZB, Horwitz RI. Resolving conflicting clinical trials: guidelines for meta-analysis. J Clin Epidemiol. 1988;41:503-509.
30. 30. Goldman L, Feinstein AR. Anticoagulants and myocardial infarction: the problems of pooling, drowning, and floating. Ann Intern Med. 1979;90:92-94.
31. 31. Chalmers TC, Berrier J, Sacks HS, Levin H, Reitman D, Nagalingam R. Meta-analysis of clinical trials as a scientific discipline, II: replicate variability and comparison of studies that agree and disagree. Stat Med. 1987;6:733-744.
32. 32. Gass JDM. Comparison of prognosis after enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol. 1985;103:916-923.
33. 33. Packard RBS. In malignant choroidal melanoma will a delay in radical treatment influence prognosis? Trans Ophthalmol Soc U K. 1983;103:49-53.
34. 34. Davidorf FH, Lang JR. The natural history of malignant melanoma of the choroid: small vs large tumors. Trans Am Acad Ophthalmol Otolaryngol. 1975;79:310-320.
35. 35. Curtin VT. Choroidal and ciliary body malignant melanomas. Mod Probl Ophthalmol. 1979;20:115-120.
36. 36. Hagler WS, Jarrett WH, Killian JH. The use of the 32P test in the management of malignant melanoma of the choroid: a five-year follow-up study. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:49-60.
37. 37. Augsburger JJ, Gamel JW, Sardi VF, Greenberg RA, Shields JA, Brady LW. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol. 1986;104:655-661.
38. 38. Seddon JM, Polivogianis L, Hsieh C, Albert DM, Gamel JW, Gragoudas ES. Death from uveal melanoma: number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol. 1987;105:801-806.
39. 39. Fletcher RH, Fletcher SW. Clinical research in general medical journals: a 30-year perspective. N Engl J Med. 1979;301:180-183.
40. 40. McLean IW, Foster WD, Zimmerman LE. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol. 1982;13:123-132.
41. 41. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
42. 42. Snedecor GW, Cochran WG. Statistical Methods. Ames, Iowa: Iowa State University Press; 1967:240-241.
43. 43. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101-129.
44. 44. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Stat Med. 1989;8:141-151.
45. 45. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1-30.
46. 46. Laird NM, Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care. 1990;6:5-30.
47. 47. Tukey JW. Exploratory Data Analysis. Reading, Mass: Addison-Wesley Publishing Co: 1977:39-47.
48. 48. Foulds WS, Damato BE, Burton RL. Local resection versus enucleation in the management of choroidal melanoma. Eye. 1987;1:676-679.
49. 49. Packard RBS. Pattern of mortality in choroidal malignant melanoma. Br J Ophthalmol. 1980;64:565-575.
50. 50. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983;101:1894-1899.
51. 51. Shammas HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol. 1977;95:63-69.
52. 52. Thomas JV, Green WR, Maumenee AE. Small choroidal melanomas: a long-term follow-up study. Arch Ophthalmol. 1979;97:861-864.
53. 53. Light RJ, Pillemer DB. Summing Up: The Science of Reviewing Research. Cambridge, Mass: Harvard University Press; 1984:1-63.
54. 54. Char DH, Castro JR, Kroll SM, Irvine AR, Quivey JM, Stone RD. Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol. 1990;108:209-214.
55. 55. Augsburger JJ, Gamel JW, Lauritzen K, Brady LW. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma. Am J Ophthalmol. 1990;109:585-592.
56. 56. Seddon JM, Gragoudas ES, Egan KM, et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 1990;97:769-777.
57. 57. US Department of Health and Human Services. Vital Statistics of the United States 1987: Mortality. Hyattsville, Md: US Dept of Health and Human Services, Centers for Disease Control, National Center for Health Statistics; 1990;2:pt A.
58. 58. Collaborative Ocular Melanoma Study. COMS Manual of Procedures. Springfield, Va: National Technical Information Service; 1989. NTIS Accession No. PB90-115536.